Scientists from the University of Sheffield have discovered a novel behaviour of the blood vessels of the brain in zebrafish that may explain some forms of stroke in humans.
The previously undescribed large structures are spherical and so have been termed kugeln (German for sphere) by the Sheffield team, who discovered them in collaboration with scientists from the USA and Germany.
No cell has ever been shown to develop kugeln in the past, possibly because they are easily mistaken for normal blood vessels. Kugeln contain a molecule called nitric oxide which is essential for the health of blood vessels.
Stroke is a life-threatening condition affecting more than 100,000 people in the UK each year. Some forms of stroke are caused by mutations in genes which the Sheffield researchers have shown are required to form kugeln. Although the function of kugeln is not yet fully understood, this link to genetic forms of stroke could provide new insights into neurological and cardiovascular research.
Elisabeth Kugler, a PhD student from the University of Sheffield's Department of Infection, Infection and Cardiovascular Disease and the main author of the study, said: "The finding of kugeln highlights the need for basic research to understand the mechanisms of development and disease.
"This study would not have been possible without an extremely strong international scientific team, underlining the significance of working across different countries."
The pioneering research was made possible thanks to state-of-the-art imaging with a revolutionary light sheet microscope (funded by the British Heart Foundation), and the ability to study vascular development using zebrafish as a model organism.
Elisabeth added: "We share 70 per cent of our genes with zebrafish. Therefore, zebrafish are hugely important for understanding processes that can lead to human disease."
The ground breaking research has been published in the journal EMBO reports.
Tim Chico, lead author of the study and Professor of Cardiovascular Medicine at the University of Sheffield, said: "Stroke is a devastating disease that affects millions of people and their families each year across the world.
"It is extremely exciting to discover an entirely new process that only happens in brain blood vessels, because this might explain why some mutations cause stroke but not diseases of other arteries.
"If we can discover the function of kugeln we may be able to manipulate them to reduce the effects of stroke."
The next step for researchers is to establish whether kugeln are present in human brains as well as gaining a deeper understanding of the mechanisms and functions of kugeln.
The University of Sheffield's Department of Infection, Immunity and Cardiovascular Disease is a world-leading centre pioneering discoveries which help to fight disease and inform inspirational teaching.
To study or collaborate with the Department of Infection, Immunity and Cardiovascular Disease please visit: https:/
For further information please contact: Rebecca Ferguson, Media Relations Officer, University of Sheffield, +44 (0)114 222 9859, email@example.com
Notes to editors
The study can be viewed at: https:/
The University of Sheffield
With almost 29,000 of the brightest students from over 140 countries, learning alongside over 1,200 of the best academics from across the globe, the University of Sheffield is one of the world's leading universities.
A member of the UK's prestigious Russell Group of leading research-led institutions, Sheffield offers world-class teaching and research excellence across a wide range of disciplines.
Unified by the power of discovery and understanding, staff and students at the university are committed to finding new ways to transform the world we live in.
Sheffield is the only university to feature in The Sunday Times 100 Best Not-For-Profit Organisations to Work For 2018 and for the last eight years has been ranked in the top five UK universities for Student Satisfaction by Times Higher Education.
Sheffield has six Nobel Prize winners among former staff and students and its alumni go on to hold positions of great responsibility and influence all over the world, making significant contributions in their chosen fields.
Global research partners and clients include Boeing, Rolls-Royce, Unilever, AstraZeneca, Glaxo SmithKline, Siemens and Airbus, as well as many UK and overseas government agencies and charitable foundations.